Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Forbes Medi-Tech submits patent, reports on clinical trials

July 28, 1997

New approaches to the pharmacological treatment of obesity

July 25, 1997

Infant nutrition as a way of preventing IDDM

July 25, 1997

Diabetes classification not as clear-cut as previously thought

July 25, 1997

Genetics Institute's growth factor recommended for approval by advisory committee

July 25, 1997

Selective neuropeptide Y5 receptor antagonists described by Synaptic

July 25, 1997

HRT indicated in hypertensive women

July 25, 1997

HRT inhibits ACE in postmenopausal women

July 25, 1997

More light shed on leptin and leptin receptors

July 24, 1997

FDA grants raloxifene NDA priority review status

July 24, 1997

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...